Clinical Trial Update: Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating isolated hepatic perfusion with melphalan for unresectable colorectal cancer with liver metastases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Cancer with Liver Metastases

Drugs mentioned

• Melphalan (Melphalan)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Colorectal Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED